Ideally, medical information that saves lives and reduces harm should not be up for sale — at least not to the end-user. Such material should be treated as a public good and paid for by the public, which is why research will remain free of charge. Editorials, news, clinical images, abstracts and previously published articles will also remain accessible to all readers. Access to reviews, analysis, practice, commentaries, humanities and supplements will be restricted to members of CMA, although these items will become free of charge 12 months after publication.
This is disappointing to me, since I have often taken advantage of CMAJ's open access full text content to link as resources here.